Showing results (281-290 of 292) with videos related to
Sort By:
Pageof 30
Plos One|June 7, 2013
Effects of abortion legalization in Nepal, 2001-2010Jillian T Henderson, Mahesh Puri, Maya Blum, et al.Contraception|January 4, 2026
Development of a consumer information leaflet for a prototype over-the-counter mifepristone and misoprostol medication abortion productKatherine Ehrenreich, M Antonia Biggs, Shelly Kaller, et al.American Journal of Obstetrics and Gynecology|January 11, 2025
Accuracy of survey-based assessment of eligibility for medication abortion compared with clinician assessmentLauren J Ralph, Katherine Ehrenreich, Shelly Kaller, et al.Obstetrics and Gynecology|June 8, 2022
Comprehension of an Over-the-Counter Drug Facts Label Prototype for a Mifepristone and Misoprostol Medication Abortion ProductM Antonia Biggs, Katherine Ehrenreich, Natalie Morris, et al.Frontiers in Immunology|March 18, 2026
Risk factors and surrogate indicators for cardiovascular disease are prevalent in Common Variable Immunodeficiency and associate with inflammatory phenotypeAidan Jia Sheng Yu, Fernando Moreira, Andrew Symes, et al.Journal of Clinical Immunology|April 14, 2022
SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings from the COV-AD StudyAdrian M Shields, Sian E Faustini, Harriet J Hill, et al.Contraception|July 17, 2021
Standardizing abortion research outcomes (STAR): Results from an international consensus development studyKatherine C Whitehouse, Bianca M Stifani, James M N Duffy, et al.Frontiers in Immunology|September 15, 2022
Detrimental NFKB1 missense variants affecting the Rel-homology domain of p105/p50Manfred Fliegauf, Matias Kinnunen, Sara Posadas-Cantera, et al.Frontiers in Immunology|June 20, 2022
Increased Seroprevalence and Improved Antibody Responses Following Third Primary SARS-CoV-2 Immunisation: An Update From the COV-AD StudyAdrian M Shields, Sian E Faustini, Harriet J Hill, et al.Breast Cancer Research and Treatment|January 6, 2026
RISE UP for breast cancer 2024: conference highlights & takeawaysTaylor Glatt, Katherine Leggat-Barr, Nandini Seth, et al.Pageof 30